INDIGO INFUSIONS Trademark
Trademark Overview
On Wednesday, February 28, 2024, a trademark application was filed for INDIGO INFUSIONS with the United States Patent and Trademark Office. The USPTO has given the INDIGO INFUSIONS trademark a serial number of 98425415. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, September 16, 2024. This trademark is owned by DSMD Therapeutics, Inc. The INDIGO INFUSIONS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical clinic services
General Information
Serial Number | 98425415 |
Word Mark | INDIGO INFUSIONS |
Filing Date | Wednesday, February 28, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Monday, September 16, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medical clinic services |
Classification Information
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 28, 2024 |
Primary Code | 044 |
First Use Anywhere Date | Monday, May 8, 2023 |
First Use In Commerce Date | Monday, May 15, 2023 |
Trademark Owner History
Party Name | DSMD Therapeutics, Inc |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Antonio, TX 78257 |
Trademark Events
Event Date | Event Description |
Wednesday, February 28, 2024 | NEW APPLICATION ENTERED |
Wednesday, July 10, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, September 16, 2024 | ASSIGNED TO EXAMINER |
Monday, September 16, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, September 16, 2024 | NON-FINAL ACTION E-MAILED |
Monday, September 16, 2024 | NON-FINAL ACTION WRITTEN |